Publications

Export 19 results:
Sort by: Author [ Title (Asc)] Type Year
Filters: Author is Kotelevtsev, Yuri  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
1
Holmes MC, Yau JL, Kotelevtsev Y, Mullins JJ, Seckl JR. 11 Beta-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Annals of the New York Academy of Sciences. 2003;1007:357-66. Abstract
Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proceedings of the National Academy of Sciences of the United States of America. 1997;94:14924-9. Abstract
A
Henriksen PA, Kotelevtsev Y. Application of gene expression profiling to cardiovascular disease. Cardiovasc Res. 2002;54(1):16-24. Abstract
C
Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, et al. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. The Biochemical journal. 1996;313 ( Pt 3):1007-17. Abstract
Ge Y, Bagnall A, Stricklett PK, Webb D, Kotelevtsev Y, Kohan DE. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol. 2008;295(6):F1635-40. Abstract
Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G, Lammie AG, et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. The Journal of biological chemistry. 2001;276:36727-33. Abstract
E
Hadoke PW, Christy C, Kotelevtsev YV, Williams BC, Kenyon CJ, Seckl JR, et al. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation. 2001;104:2832-7. Abstract
Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, et al. Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol. 2010;88(6):644-51. Abstract
Kelland NF, Bagnall AJ, Morecroft I, Gulliver-Sloan FH, Dempsie Y, Nilsen M, et al. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia. J Vasc Res. 2010;47(1):16-22. Abstract
F
Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, et al. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme. 2002;34:545-9. Abstract
G
Henriksen PA, Devitt A, Kotelevtsev Y, Sallenave J-. Gene delivery of the elastase inhibitor elafin protects macrophages from neutrophil elastase-mediated impairment of apoptotic cell recognition. FEBS Lett. 2004;574(1-3):80-4. Abstract
Kantachuvesiri S, Haley CS, Fleming S, Kurian K, Whitworth CE, Wenham P, et al. Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 rats. Kidney international. 1999;56:414-20. Abstract
Whitworth CE, Fleming S, Kotelevtsev Y, Manson L, Brooker GA, Cumming AD, et al. A genetic model of malignant phase hypertension in rats. Kidney international. 1995;47:529-35. Abstract
H
Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Seckl JR, et al. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. The Journal of clinical investigation. 1999;103:683-9. Abstract
I
Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinology. 2001;142:114-20. Abstract
L
Yau JL, Noble J, Kenyon CJ, Hibberd C, Kotelevtsev Y, Mullins JJ, et al. Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:4716-21. Abstract
O
Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, Kaufman MH, et al. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology. 1996;137:794-7. Abstract
P
Holmes MC, Kotelevtsev Y, Mullins JJ, Seckl JR. Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes. Molecular and cellular endocrinology. 2001;171:15-20. Abstract
T
Chapman KE, Kotelevtsev YV, Jamieson PM, Williams LJ, Mullins JJ, Seckl JR. Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochemical Society transactions. 1997;25:583-7.